Igor Kramnik, M.D., Ph.D.

Faculty and Fellows


Associate Professor of Medicine
Director of the Aerobiology Core and Investigator,
National Emerging Infectious Diseases Laboratories (NEIDL)

Education:

igor2M.D. - Samara State Medical University, Russia, 1984
Graduate School: Ph.D. Program at the Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russia. Ph.D. Thesis: Lung-specific aspects of anti-tuberculosis immunity, 1991.

Post-doctoral training:

Centre for the Study of Host Resistance, McGill University, Montreal, Canada
(mentors: Emil Skamene and Danuta Radzioch)
Albert Einstein College of Medicine, Bronx, New York (mentor: Barry R. Bloom)

Previous faculty positions:

Assistant and Associate Professor, Department of Immunology and Infectious Diseases, Harvard School of Public Health

Special Interests:

Research:

  • Mechanisms of innate host resistance and susceptibility to tuberculosis
  • Biology of tuberculosis granuloma and mechanisms of re-activation of latent tuberculosis infection
  • Genetic and epigenetic control of macrophage differentiation and function
  • Novel methodologies for the analysis of host – pathogen interactions
  • Diseases predisposing to or caused by mycobacterial infections

The emergence and global spread of infections caused by multidrug resistant and extensively drug resistant forms of Mycobacterium tuberculosis (M.tb) highlighted the importance of better understanding the tuberculosis pathogenesis in order to develop rational interventions to cure the disease and prevent epidemics. For millennia M.tb co-existed with humans causing more death than any other known infectious agent. The key element of the evolutionary successful virulence strategy of this intracellular pathogen is its ability to cause destruction in the lungs of susceptible individuals and to spread via aerosols, infecting the respiratory system of new hosts. The bacterial and hosts determinants of the lung tropism and destruction remain unknown.

We explore the pathogenesis of pulmonary tuberculosis using a mouse model for immunological and genetic analysis. As in humans, M.tb predominantly attacks mouse lungs causing various forms of the disease. In both species, the outcomes of the infection to a great extent are determined by the host genetic composition. Using forward genetic analysis we have identified and characterized major genetic loci synergistically controlling progression of pulmonary tuberculosis. A unique genetic locus sst1 (supersusceptibility to tuberculosis 1) controls the development of necrosis within tuberculosis granulomas in a lung-specific manner. Using positional cloning, we have identified a strong candidate gene within the sst1 locus, the Ipr1 (intracellular pathogen resistance 1) gene. Finding the mechanism, through which the Ipr1-encoded protein controls anti-tuberculosis immunity at biochemical, cellular, tissue-specific and whole organism levels, presents the next challenge. We also pursue characterization of novel genetic loci on chromosomes 7, 15 and 17. Revealing polymorphic genes encoded within the new loci, their individual functions and interactions will allow untangling complex genetic control of host resistance and susceptibility to tuberculosis.

A set of congenic mouse strains generated in the above studies carry various combinations of the tuberculosis resistance alleles and display different forms of the pulmonary disease following M.tb. challenge. We are developing tools for live imaging and functional assessment of the granuloma forming cells during the course of infection in genetically resistant and susceptible hosts. Modeling host – pathogen interactions in diverse, but genetically defined, hosts is also important for the characterization of the pathogen’s virulence genes, as well as the mechanisms of its adaptation and evolution under pressures generated by host immunity and anti-tuberculosis therapy.

Focused on key pathogenically relevant phenotypes in vivo, forward genetic analysis often revealed previously unknown disease pathways and biological processes. We anticipate that our work will build experimental and theoretical foundations for understanding tuberculosis granuloma as a unique and dynamic tissue, in which various immunological and homeostatic processes interact to shape the trajectory of host – pathogen interactions. This knowledge will help explain failures of anti-tuberculosis vaccines and drugs, and provide new directions for preventing and curing pulmonary tuberculosis.

Selected Publications:

  1. Alexander Pichugin, Bo-Shiun Yan, Lester Kobzik and Igor Kramnik. 2009. Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts. American Journal of Pathology 174, 2190-2201.
  2. Sissons, J., Yan, B.-S., Pichugin, A., Kirby, A., Daly, M.J., and Igor Kramnik. 2009. Multigenic control of tuberculosis resistance: analysis of a QTL on mouse chromosome 7 and its synergism with sst1. Genes Immun. Jan;10(1):37-46.
  3. Angele Nalbandian, Bo-Shiun Yan, Alexander Pichugin, Roderick Bronson and Igor Kramnik. 2009. Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control. Oncogene, 28, 1928-1938.
  4. Alexander Apt and Igor Kramnik. Man and mouse TB: contradictions and solutions. 2009. Tuberculosis (Edinb) 89, 195-198.
  5. Kramnik, I. 2008 Genetic Dissection of Host Resistance to Mycobacterium tuberculosis: the sst1 locus and the Ipr gene. In: Current Topics in Microbiology and Immunology, Immunology, Phenotype First: How Mutations Have Established New Principles and Pathways in Immunology, Beutler, Bruce (Ed.), Vol. 321:123- 148.
  6. E. Schurr and I. Kramnik. 2008. Genetic control of host susceptibility to tuberculosis. In: Handbook of Tuberculosis: Molecular Biology and Biochemistry. Kaufmann, van Helden, Rubin, Britton (Eds.), WILEY-VCH Verlag, Weinheim, pp. 295 – 336.
  7. Pan H., Mostoslavsky G., Eruslanov E., Kotton D.N., and Igor Kramnik. 2008. Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages. J Immunol Methods, Jan 1;329 (1-2):31-44.
  8. Yan, B.S., Pichugin, A., Ousman J., Helming L., Eruslanov E., Gutierrez-Pabello J., Rojas-Lopez, M., Shebzukhov Y. V., Kobzik L., and Igor Kramnik. 2007. Progression of Pulmonary Tuberculosis and Efficiency of Bacillus Calmette-Guerin Vaccination Are Genetically Controlled via a Common sst1-Mediated Mechanism of Innate Immunity. J Immunol 179 (10): 6919 -6932.
  9. Yan, B. S., A. Kirby, Y. V. Shebzukhov, M. J. Daly, and I. Kramnik. 2006. Genetic architecture of tuberculosis resistance in a mouse model of infection. Genes Immun 7:201-10.
  10. Hui Pan, Bo-Shiun Yan, Mauricio Rojas, Yuriy V. Shebzukhov, Hongwei Zhou, Lester Kobzik, Derren Higgins, Mark Daly, Barry R.Bloom, and Igor Kramnik. Ipr1 gene mediates innate immunity to tuberculosis. Nature, 2005, 434: 767-772.

Selected reprints:

  1. Ipr1 gene mediates innate immunity to tuberculosis
  2. Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas
  3. Lung carcinogenesis induced by chronic tuberculosis infection